Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Smart, M. Gunthorpe, J. Jerman, S. Nasir, J. Gray, A. Muir, J. Chambers, A. Randall, J. Davis (2000)
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)British Journal of Pharmacology, 129
S. Welch, John Huffman, J. Lowe (1998)
Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.The Journal of pharmacology and experimental therapeutics, 286 3
J. Jerman, S. Brough, R. Prinjha, M. Harries, John Davis, Darren Smart (2000)
Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacologyBritish Journal of Pharmacology, 130
A. Coutts, R. Pertwee (1997)
Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea‐pig myenteric plexusBritish Journal of Pharmacology, 121
M. Rinaldi-Carmona, F. Barth, J. Millan, J. Derocq, P. Casellas, C. Congy, Didier Oustric, Martine Sarran, M. Bouaboula, B. Calandra, Marielle Portier, D. Shire, J. Breliere, Gérard, Le, Fur (1998)
SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.The Journal of pharmacology and experimental therapeutics, 284 2
M. Rinaldi-Carmona, F. Barth, M. Héaulme, D. Shire, B. Calandra, C. Congy, Serge Martinez, J. Maruani, G. Néliat, D. Caput, P. Ferrara, P. Soubrié, J. Breliere, G. Fur (1994)
SR141716A, a potent and selective antagonist of the brain cannabinoid receptorFEBS Letters, 350
L. Barthó, L. Lénárd, R. Patacchini, V. Halmai, M. Wilhelm, Peter Holzer, C. Maggi (1999)
Tachykinin receptors are involved in the “local efferent” motor response to capsaicin in the guinea-pig small intestine and oesophagusNeuroscience, 90
H. Kilbinger, I. Wessler (1980)
Inhibition by acetylcholine of the stimulation-evoked release of [3H]acetylcholine from the guinea-pig myenteric plexusNeuroscience, 5
R. Pertwee, Graeme Griffin, S. Fernando, Xiuyan Li, Adam Hill, Alexandros Makriyannis (1995)
AM630, a competitive cannabinoid receptor antagonist.Life sciences, 56 23-24
R. Pertwee, S. Fernando, J. Nash, A. Coutts (1996)
Further evidence for the presence of cannabinoid CB1 receptors in guinea‐pig small intestineBritish Journal of Pharmacology, 118
V. Marzo, D. Melck, T. Bisogno, L. Petrocellis (1998)
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory actionTrends in Neurosciences, 21
P. Zygmunt, J. Petersson, D. Andersson, H. Chuang, M. Sørgård, V. Marzo, D. Julius, E. Högestätt (1999)
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamideNature, 400
P. Holzer (1991)
Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons.Pharmacological reviews, 43 2
A. Szallasi, P. Blumberg (1999)
Vanilloid (Capsaicin) receptors and mechanisms.Pharmacological reviews, 51 2
P. Holzer, U. Holzer‐Petsche (1997)
Tachykinins in the gut. Part I. Expression, release and motor function.Pharmacology & therapeutics, 73 3
MANG MANG, GEBER GEBER, KILBINGER KILBINGER (2000)
Effects of capsaicin on acetylcholine (ACh) release from guinea‐pig myenteric plexusNaunyn-Schmiedeberg's Arch. Pharmacol., 361
R. Pertwee (1999)
Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors.Life sciences, 65 6-7
R. Pertwee, S. Fernando, G. Griffin, V. Abadji, A. Makriyannis (1995)
Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations.European journal of pharmacology, 272 1
I. Adams, D. Compton, B. Martin (1998)
Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.The Journal of pharmacology and experimental therapeutics, 284 3
S. Bevan, S. Hothi, G. Hughes, I. James, H. Rang, K. Shah, C. Walpole, J. Yeats (1992)
Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicinBritish Journal of Pharmacology, 107
H. Schwörer, W. Schmidt, S. Katsoulis, W. Creutzfeldt (1991)
Calcitonin Gene-Related Peptide (CGRP) modulates cholinergic neurotransmission in the small intestine of man, pig and guinea-pig via presynaptic CGRP receptorsRegulatory Peptides, 36
A. Izzo, N. Mascolo, F. Borrelli, F. Capasso (1998)
Excitatory transmission to the circular muscle of the guinea‐pig ileum: evidence for the involvement of cannabinoid CB1 receptorsBritish Journal of Pharmacology, 124
R. Furchgott (1972)
The Classification of Adrenoceptors (Adrenergic Receptors). An Evaluation from the Standpoint of Receptor Theory
MANG MANG, ERBELDING ERBELDING, KILBINGER KILBINGER (2001)
Differential effects of anandamide in basal and evoked release of acetylcholine (ACh) from guinea‐pig ileumNaunyn-Schmiedeberg's Arch. Pharmacol., 363
The effects of anandamide on (3H)‐acetylcholine release and muscle contraction were studied on the myenteric plexus‐longitudinal muscle preparation of the guinea‐pig ileum preincubated with (3H)‐choline. Anandamide increased both basal (3H)‐acetylcholine release (pEC50 6.3) and muscle tone (pEC50 6.3). The concentration‐response curves for anandamide were shifted to the right by 1 μM capsazepine (pKB 7.5 and 7.6), and by the combined blockade of NK1 and NK3 tachykinin receptors with the antagonists CP99994 plus SR142801 (each 0.1 μM). The CB1 and CB2 receptor antagonists, SR141716A (1 μM) and SR144528 (30 nM), did not modify the facilitatory effects of anandamide. Anandamide inhibited the electrically‐evoked release of (3H)‐acetylcholine (pEC50 5.8) and contractions (pEC50 5.2). The contractile response to the muscarinic agonist methacholine was not significantly affected by 10 μM anandamide. The inhibitory effects of anandamide were not changed by either capsazepine (1 μM), SR144528 (30 nM) or CP99994 plus SR142801 (each 0.1 μM). SR141716A (1 μM) produced rightward shifts in the inhibitory concentration‐response curves for anandamide yielding pKB values of 6.6 and 6.2. CP55940 inhibited the evoked (3H)‐acetylcholine release and contractions, and SR141716A (0.1 μM) shifted the concentration‐response curves of CP55940 to the right with pKB values of 8.4 and 8.9. The experiments confirm the existence of release‐inhibitory CB1 receptors on cholinergic myenteric neurones. We conclude that anandamide inhibits the evoked acetylcholine release via stimulation of a receptor that is different from the CB1 and CB2 receptor. Furthermore, anandamide increases basal acetylcholine release via stimulation of vanilloid receptors located at primary afferent fibres. British Journal of Pharmacology (2001) 134, 161–167; doi:10.1038/sj.bjp.0704220
British Journal of Pharmacology – Wiley
Published: Sep 1, 2001
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.